Prospective Evaluation of Anorganic Bovine Bone Mineral Versus Calcium Phosphosilicate Alloplastic Bone Putty in Direct Sinus Augmentation: a Spilt-mouth Study

The purpose of this split-mouth clinical study is to evaluate the clinical, radiographic and histological outcomes of lateral window sinus augmentation with a bovine xenograft or a CPS putty bone substitute in posterior maxillary sites and the survival of implants placed in these sites following healing.

开始日期2013-10-01

申办/合作机构

University of Minnesota

[+1]

100 项与 NovaBone Products LLC 相关的临床结果

登录后查看更多信息

0 项与 NovaBone Products LLC 相关的专利（医药）

登录后查看更多信息

项与 NovaBone Products LLC 相关的文献（医药）

Polymers3区 · 工程技术

Comparison of Synthetic vs. Biogenic Polymeric Process-Directing Agents for Intrafibrillar Mineralization of Collagen

3区 · 工程技术

ArticleOA

作者: Guarnizo, Vanessa ; Gower, Laurie B. ; Cremer, Maegan A. ; Mizels, Joshua ; Saxena, Neha ; Rodriguez, Douglas E.

With the aging population, there is a growing need for mineralized tissue restoration and synthetic bone substitutes. Previous studies have shown that a polymer-induced liquid-precursor (PILP) process can successfully mineralize collagen substrates to achieve compositions found in native bone and dentin. This process also leads to intrafibrillar apatitic crystals with their [001] axes aligned roughly parallel to the long axis of the collagen fibril, emulating the nanostructural organization found in native bone and dentin. When demineralized bovine bone was remineralized via the PILP process using osteopontin (OPN), the samples were able to activate mouse marrow-derived osteoclasts to similar levels to those of native bone, suggesting a means for fabricating bioactive bone substitutes that could trigger remodeling through the native bone multicellular unit (BMU). In order to determine if OPN derived from bovine milk could be a cost-effective process-directing agent, the mineralization of type I collagen scaffolds using this protein was compared to the benchmark polypeptide of polyaspartic acid (sodium salt; pAsp). In this set of experiments, we found that OPN led to much faster and more uniform mineralization when compared with pAsp, making it a cheaper and commercially attractive alternative for mineralized tissue restorations.

Clinical applications of bioactive glass: orthopaedics

作者: Hench, Larry L. ; Gaisser, David M.

A review.This article reviews some case histories and a clin. trial that compares 45S5 Bioglass synthetic graft with autogeneous bone grafts.Use of the synthetic graft can minimize the need for second site surgery to obtain autogeneous bone in elderly patients or in cases where the quality of bone has been compromised by various factors, such as osteoporosis.

项与 NovaBone Products LLC 相关的新闻（医药）

2024-08-21

·Business Wire

Bioactive Glass Business Analysis Report 2024: Multifunctional Bioactive Glass Rises in Popularity, Enhanced Biocompatibility and Efficacy Drive Adoption of Bioactive Glass Compositions - ResearchAndMarkets.com

DUBLIN--( BUSINESS WIRE )--The "Bioactive Glass - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Bioactive Glass is estimated at US$1.0 Billion in 2023 and is projected to reach US$3.1 Billion by 2030, growing at a CAGR of 17.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The growth in the bioactive glass market is driven by several factors, including technological innovations, increasing clinical acceptance, and expanding applications in the medical field. The continuous improvement in glass formulations and processing techniques has resulted in products that offer better performance and greater versatility, catering to a broader range of medical procedures. Clinical studies validating the efficacy and benefits of bioactive glass in tissue regeneration and infection control have bolstered its adoption among healthcare providers. Additionally, there is a growing trend of personalized medicine where materials like bioactive glass are used to develop customized solutions for individual patients, further propelling market growth. Economic factors, such as the rising healthcare expenditure globally and the increasing investment in biomedical research, also play significant roles in the expansion of this market. These elements collectively ensure that the demand for bioactive glass remains robust, reflecting its critical role in advancing medical treatments and improving patient outcomes. Key Insights: Market Growth: Understand the significant growth trajectory of the Silicate-based Glass segment, which is expected to reach US$1.6 Billion by 2030 with a CAGR of a 18.0%. The Phosphate-based Glass segment is also set to grow at 17.0% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, estimated at $268.4 Million in 2023, and China, forecasted to grow at an impressive 16.2% CAGR to reach $474.1 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Why You Should Buy This Report: Detailed Market Analysis: Access a thorough analysis of the Global Bioactive Glass Market, covering all major geographic regions and market segments. Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies. Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Bioactive Glass Market. Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions. Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of major players such as Arthrex, Inc, BioMin Technologies Limited, Bonalive Biomaterials Ltd, and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. Key Questions Answered: How is the Global Bioactive Glass Market expected to evolve by 2030? What are the main drivers and restraints affecting the market? Which market segments will grow the most over the forecast period? How will market shares for different regions and segments change by 2030? Who are the leading players in the market, and what are their prospects? Key Attributes: Report Attribute Details No. of Pages 177 Forecast Period 2023 - 2030 Estimated Market Value (USD) in 2023 $1 Billion Forecasted Market Value (USD) by 2030 $3.1 Billion Compound Annual Growth Rate 17.3% Regions Covered Global MARKET OVERVIEW Influencer Market Insights World Market Trajectories Global Economic Update Bioactive Glass - Global Key Competitors Percentage Market Share in 2024 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E) MARKET TRENDS & DRIVERS Increasing Use in Bone Regeneration Bodes Well for Market Growth Expanding Use in dental Fields Drive Market Growth Enhanced Biocompatibility and Efficacy Drive Adoption of Bioactive Glass Compositions Growing Geriatric Population and Prevalence of Orthopedic and Dental Disorders Bioactive Glasses Make Their Mark in Wound Healing Applications Shifts in Healthcare Spending Towards Advanced Biomedical Materials Multifunctional Bioactive Glass Rises in Popularity FOCUS ON SELECT PLAYERS (Total 39 Featured) Arthrex, Inc BioMin Technologies Limited Bonalive Biomaterials Ltd DePuy Synthes LASAK s.r.o. Matexcel Mo-Sci Corporation NanoFUSE Biologics LLC Noraker NovaBone Products LLC Schott AG Stryker Corporation Synergy Biomedical, LLC SynThera Biomedical Pvt. Ltd Vedayukt India Private Limited For more information about this report visit https://www.researchandmarkets.com/r/fzavs4 About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

2023-11-14

·PRNewswire

Bone Graft Substitutes Business Research Report 2023: A Global $5.3 Billion Market by 2030 - Synthetic Bone Graft Substitutes Continue to Grow in Popularity

DUBLIN, Nov. 14, 2023 /PRNewswire/ -- The "Bone Graft Substitutes - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Bone Graft Substitutes Market to Reach $5.3 Billion by 2030 The global market for Bone Graft Substitutes estimated at US$3.2 Billion in the year 2022, is projected to reach a revised size of US$5.3 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2022-2030. Allograft, one of the segments analyzed in the report, is projected to record 5.6% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Synthetic segment is estimated at 7.5% CAGR for the next 8-year period. The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 10.6% CAGR The Bone Graft Substitutes market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$547.4 Million by the year 2030 trailing a CAGR of 10.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 6.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR. What`s New? Special discussions on the global economic climate and market sentiment Coverage on global competitiveness and key competitor percentage market shares Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-peer collaborative bespoke updates Access to digital archives and trademarked research platform Complimentary updates for one year MARKET OVERVIEW Pandemic Impact and Global Economic Update From Pandemic to War & Inflation: "Gloomy Outlook for 2023 Despite Signs of Easing Inflationary Conditions" Here's How Inflationary Pressures Affect the Economy Russia-Ukraine War, the Primary Culprit Responsible for the Hardships Although Past Peak in 2023, Efforts to Solve the Inflation Puzzle Should Continue Although Facing a Lower Recession Risk, Global Economic Growth in 2023 to Slowdown Amid War, Inflation, Elevated Interest Rates & Marginal Easing of Inflation: World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020 Through 2024 COVID-19 Pandemic Impacts Orthopedic Surgery Volumes Number of Elective Orthopedic Surgical Procedures Conducted in the US: April-June 2020 Vs April-June 2019 Demand for Bone Graft Substitutes Impacted by the Pandemic Bone Grafts: A Prelude An Introduction Bone Graft Substitutes A Peek into Mechanism of Action of Bone Graft Substitutes Types of Bone Grafts Applications of Bone Graft Substitutes Global Market Outlook Segment Analysis Developing Regions to Spearhead Future Growth Competition Bone Graft Substitutes - Global Key Competitors Percentage Market Share in 2023 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E) World Brands Recent Market Activity MARKET TRENDS & DRIVERS Sustained Rise in the Volume of Orthopedic Procedures Boosts Prospects Global Orthopedics Market by Segment (in %) for 2023E Increase in Number of Fractures Fuels Demand for Bone Growth Substitutes Percentage Share Breakdown of Number of Fractures by Age Group: 2022 Select Musculoskeletal Conditions - Percentage Breakdown by Age Group Increasing Cases of Trauma Underpins Demand Rise in Incidence of Osteoporosis to Benefit Market Growth Global Osteoporosis Prevalence: Number of People with Osteoporosis in Millions by Select Country/Region for 2012 and 2022E % of Women Affected by Osteoporosis Market to Benefit from the Rising Prevalence of Arthritis and Other Orthopedic Disorders Increasing Incidence of Degenerative Intervertebral Disc Diseases Supports Market Spinal Fusion Surgery Holds Strong Opportunities US Spinal Fusion Surgery Market: Percentage Breakdown of Procedure Volume by Age Group Foot & Extremity Reconstruction Presents Opportunities for Bone Grafting Dental Bone Graft Substitutes Market: Poised for High Growth Dental Implants Penetration Worldwide - Number of Patients Treated Per 10,000 Persons in Select Countries Dental Bone Graft and Substitutes Market Breakdown by Material (in %) for 2023E Increasing Visibility of Orthobiological Products to Spur Grafting Options What Drives Physicians' Choice of Bone Grafts? Patient Safety Emerges as a Top Priority Bone Grafting - A Review of Select Commercial Solutions Precision Machined Allografts Gain Surgeon Preference Advanced Allografts Emerge as Replacements for Autografts in Surgical Procedures Synthetic Bone Graft Substitutes Continue to Grow in Popularity Significance of Synthetic Bone Grafts in Dental Treatment Current Developments in Artificial Bone Grafts Bone Morphogenetic Protein - Promising Outlook Despite Safety Concerns DBM: Strong Growth but Tough Competition Stem Cell Based Bone Grafts: Promising Growth Ahead Technological Advancements Drive Bone Grafts Market Aging Population and Their Increased Vulnerability to Bone & Joint-Related Disorders Drive Market Growth Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 Rise in Global Obesity Epidemic Boosts Market Growth Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P Rising Healthcare Spending Augurs Well for the Market World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023 Major Challenges Confronting Bone Graft Substitutes Market FOCUS ON SELECT PLAYERS (Total 147 Featured) AlloSource Baxter International, Inc. DePuy Synthes Companies Exactech, Inc. LifeNet Health, Inc. Medtronic plc NovaBone Products LLC NuVasive, Inc. Orthofix US LLC RTI Surgical, Inc. SeaSpine Orthopedics Corporation Smith & Nephew Plc Stryker Corporation Wright Medical Group N.V. Xtant Medical Holdings, Inc. Zimmer Biomet For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Logo: SOURCE Research and Markets

2023-03-07

·国家药品监督管理局政务服务门户

2023年03月07日医疗器械批准证明文件送达信息发布

2022年11月1日起，行政相对人可登录网上办事大厅的法人空间查看电子证照，按照法人空间内相关提示自行打印。序号受理号产品名称申请人代理人注册证编号批准日期1CQD2300307一次性使用无菌胰岛素注射器普昂（杭州）医疗科技股份有限公司/国械注准20223140042 2023-03-02 2CQD2300308一次性输液延长管上海正邦医疗科技有限公司/国械注准20233140211 2023-03-02 3CQD2300309一次性使用静脉血样采集针威海威高采血耗材有限公司/国械注准20173221454 2023-03-03 4CQD2300310一次性使用无菌注射器带针江苏治宇医疗器材有限公司/国械注准20173140338 2023-03-03 5CQD2300311玻璃化冷冻液套装江苏瑞辅达医疗器械有限公司/国械注准20223180953 2023-03-03 6CQD2300312血浆分离机海尔血液技术重庆有限公司/国械注准20183101654 2023-03-03 7CQD2300313一次性使用微孔过滤输液器河南驼人鑫安医疗器械有限公司/国械注准20223140804 2023-03-03 8CQD2300314一次性使用导管鞘组深圳市业聚实业有限公司/国械注准20223030012 2023-03-03 9CQD2300315一次性使用注射笔用针头普昂（杭州）医疗科技股份有限公司/国械注准20223140645 2023-03-03 10CQD2300316人工晶状体爱博诺德（北京）医疗科技股份有限公司/国械注准20183160052 2023-03-03 11CQD2300317界面螺钉上海利格泰生物科技股份有限公司/国械注准20223131482 2023-03-03 12CQD2300318高频电刀常州市延陵电子设备有限公司/国械注准20153011796 2023-03-03 13CQD2300319病人监护仪深圳市科曼医疗设备有限公司/国械注准20223071749 2023-03-03 14CQD2300320一次性使用血液透析管路福建长庚医疗生物科技有限公司/国械注准20173101543 2023-03-03 15CQD2300321一次性使用高频双极手术电极山东康盛医疗器械有限公司/国械注准20223011750 2023-03-03 16CQD2300322一次性使用压力传感器深圳库珀医疗股份有限公司/国械注准20173070980 2023-03-06 17CQD2300324微导管深圳市业聚实业有限公司/国械注准20203030533 2023-03-06 18CQX2200197病人监护仪深圳迈瑞生物医疗电子股份有限公司/国械注准20173211480 2023-03-03 19CQX2200199病人监护仪深圳迈瑞生物医疗电子股份有限公司/国械注准20173070926 2023-03-03 20CQX2200557全膝关节置换手术导航定位系统北京和华瑞博医疗科技有限公司/国械注准20223010113 2023-03-03 21CQZ2000198富血小板血浆制备用套装北京上惠好医疗器械有限公司/国械注准20233100234 2023-03-07 22CQZ2000700颗粒细胞去除液东蕴医疗科技（上海）有限公司/国械注准20233180229 2023-03-07 23CQZ2100411牙种植体系统百齿泰（厦门）医疗科技有限公司/国械注准20233170238 2023-03-07 24CQZ2100423负压辅助静脉引流控制器西安西京医疗用品有限公司/国械注准20233100258 2023-03-07 25CQZ2100683枕颈胸后路内固定系统创辉医疗器械江苏有限公司/国械注准20233130239 2023-03-07 26CQZ2100944心电图房颤分析软件深圳市理邦精密仪器股份有限公司/国械注准20233210249 2023-03-07 27CQZ2101038锁定型金属万向加压接骨板钉系统北京中安泰华科技有限公司/国械注准20233130221 2023-03-07 28CQZ2101077一次性使用双极高频内窥镜手术电极浙江量子医疗器械有限公司/国械注准20233010257 2023-03-07 29CQZ2101105一次性使用精密过滤输液器带针稳健平安医疗科技（湖南）有限公司/国械注准20233140245 2023-03-07 30CQZ2101113一次性使用输液器带针稳健平安医疗科技（湖南）有限公司/国械注准20233140247 2023-03-07 31CQZ2101212等离子手术设备上海朗迈医疗器械科技有限公司/国械注准20233010250 2023-03-07 32CQZ2101214椎板固定板系统山东威高海星医疗器械有限公司/国械注准20233130230 2023-03-07 33CQZ2101231一次性使用避光输液器带针上海正邦医疗科技有限公司/国械注准20233140220 2023-03-07 34CQZ2101285口腔修复膜青岛杰圣博生物科技有限公司/国械注准20233170232 2023-03-07 35CQZ2101390胸腰椎后路钉棒内固定系统北京安颂科技有限公司/国械注准20233130227 2023-03-07 36CQZ2101420胸腰椎后路内固定系统联科医疗器材（重庆）有限公司/国械注准20233130243 2023-03-07 37CQZ2101473颈椎前路自稳定型融合器浙江德康医疗器械有限公司/国械注准20233130241 2023-03-07 38CQZ2200019神经监护气管插管江苏百宁盈创医疗科技有限公司/国械注准20233070252 2023-03-07 39CQZ2200132门型钉常州市天晟医疗器械有限公司/国械注准20233130228 2023-03-07 40CQZ2200139自稳型颈椎椎间融合器北京市春立正达医疗器械股份有限公司/国械注准20233130246 2023-03-07 41CQZ2200180可吸收界面螺钉山东威高骨科材料股份有限公司/国械注准20233130226 2023-03-07 42CQZ2200197颈椎后路内固定系统浙江嘉佑医疗器械有限公司/国械注准20233130235 2023-03-07 43CQZ2200226牙科激光选区熔化钴铬合金粉山东迈得新材料有限公司/国械注准20233170240 2023-03-07 44CQZ2200233半导体激光治疗仪桂林市啄木鸟医疗器械有限公司/国械注准20233010261 2023-03-07 45CQZ2200330单髁膝关节系统北京科仪邦恩医疗器械科技有限公司/国械注准20233130244 2023-03-07 46CQZ2200352种植体系统无锡领缔生物科技有限公司/国械注准20233170222 2023-03-07 47CQZ2200386冠脉造影血流储备分数计算设备杭州脉流科技有限公司/国械注准20233070251 2023-03-07 48CQZ2200423软性亲水接触镜爱睿思(厦门)科技有限公司/国械注准20233160225 2023-03-07 49CQZ2200494全自动核酸检测分析系统广州达安基因股份有限公司/国械注准20233220248 2023-03-07 50CQZ2200607柠檬酸消毒液山东消博士消毒科技股份有限公司/国械注准20233100242 2023-03-07 51CQZ2200609全自动核酸检测分析系统奥然生物科技（上海）有限公司/国械注准20233220259 2023-03-07 52CQZ2200658可调节带袢钛板海南苏生生物科技有限公司/国械注准20233130236 2023-03-07 53CQZ2200664X射线计算机体层摄影设备扬州开影医疗有限公司/国械注准20233060256 2023-03-07 54CQZ2200682一次性使用补液管路河南省驼人医疗科技有限公司/国械注准20233100231 2023-03-07 55CQZ2200691远端通路导管赛诺神畅医疗科技有限公司/国械注准20233030237 2023-03-07 56CQZ2200767上肢锁定接骨板系统宁波兆盈医疗器械有限公司/国械注准20233130223 2023-03-07 57CQZ2200805颅颌面内固定钛钉广州迈普再生医学科技股份有限公司/国械注准20233130224 2023-03-07 58CQZ2201167金属髓内针宁波兆盈医疗器械有限公司/国械注准20233130233 2023-03-07 59CSD2300314新型冠状病毒（2019-nCoV）IgM抗体检测试剂盒(胶体金法)北京贝尔生物工程股份有限公司/国械注准20223400363 2023-03-02 60CSD2300315A群轮状病毒检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20153401716 2023-03-02 61CSD2300316柯萨奇病毒B组IgM抗体检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20153400144 2023-03-02 62CSD2300317人副流感病毒IgM抗体检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20183400002 2023-03-02 63CSD2300318沙眼衣原体抗原检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20163402489 2023-03-03 64CSD2300319肺炎支原体IgM抗体检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20153401717 2023-03-03 65CSD2300320风疹病毒抗体（IgG)检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20163402484 2023-03-03 66CSD2300321呼吸道合胞病毒IgM抗体检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20153400145 2023-03-03 67CSD2300322单纯疱疹病毒I型IgM抗体检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20183400005 2023-03-03 68CSD2300323戊型肝炎病毒IgM抗体检测试剂盒（磁微粒化学发光法）北京贝尔生物工程股份有限公司/国械注准20193400788 2023-03-03 69CSD2300324埃可病毒IgM抗体检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20153400142 2023-03-03 70CSD2300325戊型肝炎病毒抗体（IgM）检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20153401715 2023-03-03 71CSD2300326肺炎衣原体IgM抗体检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20153400146 2023-03-03 72CSD2300327戊型肝炎病毒抗体（IgG）检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20153401714 2023-03-03 73CSD2300328单纯疱疹病毒Ⅱ型抗体（IgG)检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20163402486 2023-03-03 74CSD2300329甲型肝炎病毒IgM抗体检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20153400195 2023-03-03 75CSD2300330梅毒螺旋体抗体检测试剂盒（乳胶法）杭州奥泰生物技术股份有限公司/国械注准20233400005 2023-03-03 76CSD2300331肺炎链球菌抗原检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20153400192 2023-03-06 77CSD2300332结核分枝杆菌IgG抗体检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20163400934 2023-03-06 78CSD2300333新型冠状病毒（2019-nCoV）抗原检测试剂盒（胶体金法）浙江东方基因生物制品股份有限公司/国械注准20223400359 2023-03-06 79CSD2300334人细小病毒B19IgM抗体检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20153400189 2023-03-06 80CSD2300335腺病毒IgM抗体检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20183400003 2023-03-06 81CSD2300336幽门螺旋杆菌抗体（IgG）检测试剂盒（胶体金法）北京贝尔生物工程股份有限公司/国械注准20153401718 2023-03-06 82CSY2300014布鲁氏菌抗体检测试剂（胶体金法）北京金豪制药股份有限公司/国械注准20183400290 2023-03-03 83CSY2300015丙型肝炎病毒抗体检测试剂盒（直接化学发光法）迈克生物股份有限公司/国械注准20183400326 2023-03-03 84CSY2300018人类免疫缺陷病毒抗原抗体检测试剂盒（直接化学发光法）迈克生物股份有限公司/国械注准20183400327 2023-03-03 85CSY2300019乙型流行性感冒病毒抗原检测试剂盒（胶体金法）英科新创（厦门）科技股份有限公司/国械注准20143401924 2023-03-03 86CSY2300024淋球菌抗原检测试剂盒（免疫层析法）山东康华生物医疗科技股份有限公司/国械注准20183401863 2023-03-03 87CSY2300025乙型肝炎病毒表面抗体检测试剂盒（胶体金法）英科新创（厦门）科技股份有限公司/国械注准20143401996 2023-03-03 88CSY2300026甲型/乙型流行性感冒病毒抗原检测试剂盒（胶体金法）英科新创（厦门）科技股份有限公司/国械注准20143401922 2023-03-03 89CSZ2100263戊型肝炎病毒IgG抗体检测试剂盒（酶联免疫法）上海科华生物工程股份有限公司/国械注准20233400260 2023-03-07 90CSZ2100329曲霉半乳甘露聚糖IgG抗体检测试剂盒（化学发光法）丹娜（天津）生物科技股份有限公司/国械注准20233400255 2023-03-07 91CSZ2200048甲胎蛋白 (AFP)测定试剂盒（化学发光法）昆明思安生物科技有限公司/国械注准20233400254 2023-03-07 92CSZ2200099人PAX1和JAM3基因甲基化检测试剂盒(PCR-荧光探针法)北京起源聚禾生物科技有限公司/国械注准20233400253 2023-03-07 93CSZ2200199肿瘤标志物质控品郑州标源生物科技有限公司/国械注准20233400212 2023-02-23 94JQD2300217一次性使用配药用过滤器Pall Medical, a Division of Pall International Sàrl格来赛生命科技（上海）有限公司国械注进20222140414 2023-03-02 95JQD2300218医用空气压缩机Hamilton Medical AG哈美顿医疗科技（北京）有限公司国械注进20162080405 2023-03-02 96JQD2300219粘接剂MICERIUM S.P.A.北京固琦口腔科技有限公司国械注进20163170137 2023-03-02 97JQD2300220高频手术系统Sutter Medizintechnik GmbH泰世德（北京）医药科技有限公司国械注进20153010208 2023-03-03 98JQD2300221乳腺定位针Argon Medical Devices, Inc.爱琅（上海）医疗器械有限公司国械注进20222020429 2023-03-03 99JQD2300222电子支气管内窥镜KARL STORZ SE & Co. KG卡尔史托斯内窥镜（上海）有限公司国械注进20143065496 2023-03-03 100JQD2300223牙胶充填仪DiaDent Group International北京达雅鼎医疗器械有限公司国械注进20192170419 2023-03-06 101JQD2300224呼吸机Hamilton Medical AG哈美顿医疗科技（北京）有限公司国械注进20173081064 2023-03-06 102JQX2100225眼科手术显微镜LuxOR Ophthalmic MicroscopeAlcon Laboratories, Incorporated爱尔康（中国）眼科产品有限公司国械注进20162161947 2023-03-03 103JQX2100428经颅多普勒仪Compumedics Germany GmbH北京市北科数字医疗技术有限公司国械注进20182230085 2023-03-03 104JQX2200044超声诊断仪SAMSUNG MEDISON CO., LTD.三星（中国）投资有限公司国械注进20192060275 2023-03-03 105JQX2200842眼前节光学相干断层扫描仪株式会社トーメーコーポレーション北京纽创科技有限公司国械注进20203160473 2023-03-03 106JQX2201298植入式神经刺激系统经皮电极套件Abbott Medical雅培医疗用品（上海）有限公司国械注进20173126226 2023-03-03 107JQX2201310电生理电极导管St. Jude Medical雅培医疗用品（上海）有限公司国械注进20173070679 2023-03-03 108JQZ2000391口腔用人工骨NovaBone Products, LLC美国诺邦生物制品有限公司上海代表处国械注进20233170067 2023-03-07 109JQZ2100505连续性血液净化透析滤过器及配套管路Gambro Industries百特医疗用品贸易（上海）有限公司国械注进20233100070 2023-03-07 110JQZ2100521数字化X射线摄影透视系统Siemens Healthcare GmbH西门子医疗系统有限公司国械注进20233060071 2023-03-07 111JQZ2100599种植体附件Biomet 3i, LLC皆美（上海）医疗器械有限公司国械注进20233170069 2023-03-07 112JQZ2100648膝关节置换手术导航系统Blue Belt Technologies, Inc.施乐辉医用产品国际贸易（上海）有限公司国械注进20233010072 2023-03-07 113JQZ2200089注射用交联透明质酸钠凝胶GENOSS Co., Ltd.登腾（上海）医疗器械有限公司国械注进20233130068 2023-03-07 114JSY2300067糖化血红蛋白质控品Abbott GmbH雅培贸易（上海）有限公司国械注进20142405363 2023-03-03 115JSY2300069甲型肝炎病毒抗体（IgM）检测试剂盒（电化学发光法）Roche Diagnostics GmbH罗氏诊断产品（上海）有限公司国械注进20183402540 2023-03-03 116JSZ2100057结核分枝杆菌和利福平耐药基因检测试剂盒（实时荧光PCR-熔解曲线法）Cepheid AB赛沛（上海）商贸有限公司国械注进20233400073 2023-03-07

申请上市

100 项与 NovaBone Products LLC 相关的药物交易

登录后查看更多信息

100 项与 NovaBone Products LLC 相关的转化医学

登录后查看更多信息